Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Nautilus Biotechnology In...

    NASDAQ: NAUT · Real-Time Price · USD
    0.73
    -0.08 (-9.54%)
    At close: Jun 27, 2025, 3:59 PM
    0.74
    2.05%
    After-hours: Jun 27, 2025, 04:50 PM EDT

    Nautilus Biotechnology Statistics

    Share Statistics

    Nautilus Biotechnology has 126.15M shares outstanding. The number of shares has increased by 0.7% in one year.

    Shares Outstanding

    n/a
    		 126.15M

    Shares Change (YoY)

    n/a
    		 0.7%

    Shares Change (QoQ)

    n/a
    		 0.47%

    Owned by Institutions (%)

    n/a
    		 50.91%

    Shares Floating

    n/a
    		 58.58M

    Failed to Deliver (FTD) Shares

    n/a
    		 72

    FTD / Avg. Volume

    n/a
    		 0.03%

    Short Selling Information

    The latest short interest is 1.05M, so 0.84% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 1.05M

    Short % of Shares Out

    n/a
    		 0.84%

    Short % of Float

    n/a
    		 2.51%

    Short Ratio (days to cover)

    n/a
    		 7.75

    Valuation Ratios

    The PE ratio is -2.98 and the forward PE ratio is -1.19. Nautilus Biotechnology's PEG ratio is -0.3.

    PE Ratio

    n/a
    		 -2.98

    Forward PE

    n/a
    		 -1.19

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 1.5

    PB Ratio

    n/a
    		 1.01

    P/FCF Ratio

    n/a
    		 -3.44

    PEG Ratio

    n/a
    		 -0.3
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Nautilus Biotechnology.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 17.4, with a Debt / Equity ratio of 0.15.

    Current Ratio

    n/a
    		 17.4

    Quick Ratio

    n/a
    		 17.4

    Debt / Equity

    n/a
    		 0.15

    Debt / EBITDA

    n/a
    		 -0.47

    Debt / FCF

    n/a
    		 -0.5

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-528,208.96

    Employee Count

    n/a
    		 134

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -65.35% in the last 52 weeks. The beta is 1.25, so Nautilus Biotechnology's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.25

    52-Week Price Change

    n/a
    		 -65.35%

    50-Day Moving Average

    n/a
    		 0.75

    200-Day Moving Average

    n/a
    		 1.67

    Relative Strength Index (RSI)

    n/a
    		 58.07

    Average Volume (20 Days)

    n/a
    		 207,808

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -81.48M

    Net Income

    n/a
    		 -70.78M

    EBITDA

    n/a
    		 -64.43M

    EBIT

    n/a
    		 -70.78M

    Earnings Per Share (EPS)

    n/a
    		 -0.56
    Full Income Statement

    Balance Sheet

    The company has 27.65M in cash and 30.48M in debt, giving a net cash position of -2.83M.

    Cash & Cash Equivalents

    n/a
    		 27.65M

    Total Debt

    n/a
    		 30.48M

    Net Cash

    n/a
    		 -2.83M

    Retained Earnings

    n/a
    		 -273.02M

    Total Assets

    n/a
    		 227.69M

    Working Capital

    n/a
    		 133.44M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -59.15M and capital expenditures -2.12M, giving a free cash flow of -61.27M.

    Operating Cash Flow

    n/a
    		 -59.15M

    Capital Expenditures

    n/a
    		 -2.12M

    Free Cash Flow

    n/a
    		 -61.27M

    FCF Per Share

    n/a
    		 -0.49
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    NAUT does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for NAUT is $3.88, which is 391.1% higher than the current price. The consensus rating is "Hold".

    Price Target

    n/a
    		 $3.88

    Price Target Difference

    n/a
    		 391.1%

    Analyst Consensus

    n/a
    		 Hold

    Analyst Count

    n/a
    		 2
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -0.47

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist